Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.
Zhou D; Wu TL; Emmer KL; Kurupati R; Tuyishime S; Li Y; Giles-Davis W; Zhou X; Xiang Z; Liu Q; Ratcliffe SJ; Ertl HC; Molecular Therapy: The Journal Of The American Society Of Gene Therapy, 2013, vol. 21, issue 3, p 696, ISSN 15250024. ISBN 15250024.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef